Holdings
ARCH Venture Management, LLC
As of Jun 30, 2026, ARCH Venture Management, LLC reported 12 positions worth US$1.1B. Largest: Parabilis Medicines, Inc., Beam Therapeutics Inc. and Rapport Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Parabilis Medicines, Inc. | 6.41M | US$176M | new | Jun 30, 2026 |
| Beam Therapeutics Inc. | 4.54M | US$156M | no change | Jun 30, 2026 |
| Rapport Therapeutics, Inc. | 3.73M | US$155M | no change | Jun 30, 2026 |
| Seaport Therapeutics, Inc. | 6.29M | US$137M | new | Jun 30, 2026 |
| Erasca, Inc. | 7.09M | US$130M | no change | Jun 30, 2026 |
| Vir Biotechnology, Inc. | 12.7M | US$129M | −223K | Jun 30, 2026 |
| Maze Therapeutics, Inc. | 4.12M | US$123M | no change | Jun 30, 2026 |
| Lyell Immunopharma, Inc. | 3.25M | US$45.5M | no change | Jun 30, 2026 |
| Generate Biomedicines, Inc. | 1.94M | US$32.8M | no change | Jun 30, 2026 |
| 10x Genomics, Inc. | 218K | US$8.35M | no change | Jun 30, 2026 |